Skip to main content
. Author manuscript; available in PMC: 2018 Jan 9.
Published in final edited form as: Cancer Prev Res (Phila). 2017 Apr 10;10(6):345–354. doi: 10.1158/1940-6207.CAPR-16-0286

Figure 4. Cell proliferation in crypts in mucosal biopsies from healthy subjects treated with linaclotide or placebo in Stage I.

Figure 4

Proliferation was quantified by enumerating cells expressing Ki67 by immunofluorescence. Ki67 was enumerated in 10–20 crypts in each biopsy and means were calculated. For each intestinal segment, the ratio of mean Ki67 expression on day 1 (pre-dose) and 7 (post-dose) were calculated. C, cecum; TC, transverse colon, R, rectum. ***, p<0.001.